Current Oncology Reports

, Volume 10, Issue 2, pp 156–161

Paragangliomas of the head and neck



Paragangliomas (PGs) are rare tumors of the head and neck that require a multidisciplinary approach to their management. The recent elucidation of the genetic and molecular etiology for this disease has led to significant advances in our understanding of this disease and has had an important clinical impact. Consideration of genetic testing is strongly suggested for selected patients and their family members. Surgical therapy remains the treatment of choice for most tumors, although a role for stereotactic radiotherapy is emerging. This review highlights some of the advances made in recent years regarding the diagnosis and treatment of PG.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Baysal BE, Ferrell RE, Willett-Brozick JE, et al.: Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000, 287:848–851.PubMedCrossRefGoogle Scholar
  2. 2.
    Neumann HP, Bausch B, McWhinney SR, et al.: Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002, 346:1459–1466.PubMedCrossRefGoogle Scholar
  3. 3.
    Astuti D, Latif F, Dallol A, et al.: Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001, 69:49–54.PubMedCrossRefGoogle Scholar
  4. 4.
    Niemann S, Muller U: Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000, 26:268–270.PubMedCrossRefGoogle Scholar
  5. 5.
    Jiménez C, Cote G, Arnold A, Gagel RF: Review: should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? J Clin Endocrinol Metab 2006, 91:2851–2858.PubMedCrossRefGoogle Scholar
  6. 6.
    Brandon M, Baldi P, Wallace DC: Mitochondrial mutations in cancer. Oncogene 2006, 25:4647–4662.PubMedCrossRefGoogle Scholar
  7. 7.
    Bourgeron T, Rustin P, Chretien D, et al.: Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995, 11:144–149.PubMedCrossRefGoogle Scholar
  8. 8.
    Benn DE, Gimenez-Roqueplo AP, Reilly JR, et al.: Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 2006, 91:827–836.PubMedCrossRefGoogle Scholar
  9. 9.
    Heutink P, van der Mey AG, Sandkuijl LA, et al.: A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. Hum Mol Genet 1992, 1:7–10.PubMedCrossRefGoogle Scholar
  10. 10.
    Amar L, Bertherat J, Baudin E, et al.: Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 2005, 23:8812–8818.PubMedCrossRefGoogle Scholar
  11. 11.
    Neumann HP, Pawlu C, Peczkowska M, et al.: Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004, 292:943–951.PubMedCrossRefGoogle Scholar
  12. 12.
    Schiavi F, Boedeker C, Bausch B, et al.: Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 2005, 294:2057–2063.PubMedCrossRefGoogle Scholar
  13. 13.
    Young WF, Jr, Abboud AL: Editorial: paraganglioma—all in the family. J Clin Endocrinol Metab 2006, 91:790–792.PubMedCrossRefGoogle Scholar
  14. 14.
    Martin TP, Irving RM, Maher ER: The genetics of paragangliomas: a review. Clin Otolaryngol 2007, 32:7–11.PubMedCrossRefGoogle Scholar
  15. 15.
    Ferner RE: Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol 2007, 6:340–351.PubMedCrossRefGoogle Scholar
  16. 16.
    Hu K, Persky MS: Multidisciplinary management of paragangliomas of the head and neck, Part 1. Oncology (Williston Park) 2003, 17:983–993.Google Scholar
  17. 17.
    van den Berg R: Imaging and management of head and neck paragangliomas. Eur Radiol 2005, 15:1310–1318.PubMedCrossRefGoogle Scholar
  18. 18.
    Arnold SM, Strecker R, Scheffler K, et al.: Dynamic contrast enhancement of paragangliomas of the head and neck: evaluation with time-resolved 2D MR projection angiography. Eur Radiol 2003, 13:1608–1611.PubMedCrossRefGoogle Scholar
  19. 19.
    van den Berg R, Verbist BM, Mertens BJ, et al.: Head and neck paragangliomas: improved tumor detection using contrast-enhanced 3D time-of-flight MR angiography as compared with fat-suppressed MR imaging techniques. AJNR Am J Neuroradiol 2004, 25:863–870.PubMedGoogle Scholar
  20. 20.
    Brink I, Hoegerle S, Klisch J, Bley TA: Imaging of pheochromocytoma and paraganglioma. Fam Cancer 2005, 4:61–68.PubMedCrossRefGoogle Scholar
  21. 21.
    Hoegerle S, Ghanem N, Altehoefer C, et al.: 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging 2003, 30:689–694.PubMedCrossRefGoogle Scholar
  22. 22.
    Pellitteri PK, Rinaldo A, Myssiorek D, et al.: Paragangliomas of the head and neck. Oral Oncol 2004, 40:563–575.PubMedCrossRefGoogle Scholar
  23. 23.
    Rao AB, Koeller KK, Adair CF: From the archives of the AFIP: paragangliomas of the head and neck: radiologicpathologic correlation. Radiographics 1999, 19:1605–1632.PubMedGoogle Scholar
  24. 24.
    Mafee MF, Raofi B, Kumar A, Muscato C: Glomus faciale, glomus jugulare, glomus tympanicum, glomus vagale, carotid body tumors, and simulating lesions. Role of MR imaging. Radiol Clin North Am 2000, 38:1059–1076.PubMedCrossRefGoogle Scholar
  25. 25.
    Antonitsis P, Saratzis N, Velissaris I, et al.: Management of cervical paragangliomas: review of a 15-year experience. Langenbecks Arch Surg 2006, 391:396–402.PubMedCrossRefGoogle Scholar
  26. 26.
    Timmers HJ, Kozupa A, Chen CC, et al.: Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol 2007, 25:2262–2269.PubMedCrossRefGoogle Scholar
  27. 27.
    Duet M, Sauvaget E, Pételle B, et al.: Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck. J Nucl Med 2003, 44:1767–1774.PubMedGoogle Scholar
  28. 28.
    Bustillo A, Telischi F, Weed D, et al.: Octreotide scintigraphy in the head and neck. Laryngoscope 2004, 114:434–440.PubMedCrossRefGoogle Scholar
  29. 29.
    Jackson CG: Glomus tympanicum and glomus jugulare tumors. Otolaryngol Clin North Am 2001, 34:941–970, vii.PubMedCrossRefGoogle Scholar
  30. 30.
    Jackson CG: Neurologic skull base surgery for glomus tumors. Diagnosis for treatment planning and treatment options. Laryngoscope 1993, 103(Pt 2 Suppl 60):17–22.PubMedGoogle Scholar
  31. 31.
    Patel SJ, Sekhar LN, Cass SP, Hirsch BE: Combined approaches for resection of extensive glomus jugulare tumors. A review of 12 cases. J Neurosurg 1994, 80:1026–1038.PubMedGoogle Scholar
  32. 32.
    Boedeker CC, Ridder GJ, Schipper J: Paragangliomas of the head and neck: diagnosis and treatment. Fam Cancer 2005, 4:55–59.PubMedCrossRefGoogle Scholar
  33. 33.
    Hu K, Persky MS: The multidisciplinary management of paragangliomas of the head and neck, Part 2. Oncology (Williston Park) 2003, 17:1143–1153; discussion 1154, 1158, 1161.Google Scholar
  34. 34.
    Pollock BE: Stereotactic radiosurgery in patients with glomus jugulare tumors. Neurosurg Focus 2004, 17:E10.PubMedCrossRefGoogle Scholar
  35. 35.
    Gerosa M, Visca A, Rizzo P, et al.: Glomus jugulare tumors: the option of gamma knife radiosurgery. Neurosurgery 2006, 59:561–569.PubMedCrossRefGoogle Scholar
  36. 36.
    Sheehan J, Kondziolka D, Flickinger J, Lunsford LD: Gamma knife surgery for glomus jugulare tumors: an intermediate report on efficacy and safety. J Neurosurg 2005, 102(Suppl):241–246.PubMedCrossRefGoogle Scholar
  37. 37.
    Gottfried ON, Liu JK, Couldwell WT: Comparison of radiosurgery and conventional surgery for the treatment of glomus jugulare tumors. Neurosurg Focus 2004, 17:E4.PubMedGoogle Scholar

Copyright information

© Current Medicine Group LLC 2008

Authors and Affiliations

  1. 1.Department of Head and Neck SurgeryThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations